NCT00652639View on ClinicalTrials.gov

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

April 30, 2004

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Clonazepam

Tablets, 1 mg, single-dose

DRUG

Klonopin

tablets, 1 mg, single-dose

Sponsors
All Listed Sponsors
collaborator

Cetero Research, San Antonio

NETWORK

lead

Par Pharmaceutical, Inc.

INDUSTRY